Back to search

Article

Targeting claudin-4 enhances chemosensitivity of triple negative breast cancer

2019-08-04

Abstract excerpt

<title>Abstract</title> <p>Background Triple negative breast cancer (TNBC) possesses highly aggressive phenotype, treatment with limited options, and a poor prognosis. In this study, we examined the therapeutic effect of anti-claudin (CLDN)-4 extracellular domain antibody, 4D3, on TNBC. Methods The expression of CLDN4 and CLDN1 in invasive ductal carcinoma (IDC) was examined in 78 IDCs (from 2004 to 2009 in a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4acd7da2-2a54-58fb-abfd-679ca9e3f289
DOI
10.21203/rs.2.12416/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting claudin-4 enhances chemosensitivity of triple negative breast cancerDOI 10.21203/rs.2.12416/v1
Select a neighboring publication to make it the new centre.